JESSICA EVERMAN: Open Payments
NPI 1225624711 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,446 in 74 payments from 17 companies in 2025. Trend: 2023 $899 · 2024 $1,576 · 2025 $2,446
Food & beverage: $2,446
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $607 |
| PFIZER INC. | 17 | $426 |
| ABBVIE INC. | 15 | $414 |
| Phathom Pharmaceuticals, Inc. | 3 | $172 |
| Alkermes, Inc. | 3 | $141 |
| ViiV Healthcare Company | 1 | $115 |
| Antares Pharma, Inc. | 4 | $110 |
| Exact Sciences Corporation | 2 | $102 |
| Lilly USA, LLC | 4 | $83 |
| AstraZeneca Pharmaceuticals LP | 3 | $71 |
Products named: VRAYLAR, NURTEC ODT, REPATHA, VOQUEZNA, LYBALVI, ZAVZPRET, APRETUDE, XYOSTED.
Industry payments across ID — which companies pay providers there.
